Raymond James Financial Services Advisors’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-23,475	Closed	-$60.1K	–	3388
2023 Q1	$60.1K	Buy	+23,475	New	+$48.4K	﹤0.01%	3116
2022 Q4	–	Sell	-22,311	Closed	-$39K	–	3406
2022 Q3	$39K	Hold	22,311	–	–	﹤0.01%	3112
2022 Q2	$29K	Hold	22,311	–	–	﹤0.01%	3133
2022 Q1	$53K	Hold	22,311	–	–	﹤0.01%	3190
2021 Q4	$102K	Sell	22,311 -7,950	-26%	-$26.3K	﹤0.01%	3120
2021 Q3	$245K	Hold	30,261	–	–	﹤0.01%	2835
2021 Q2	$297K	Buy	30,261 +1,000	+3%	+$8.13K	﹤0.01%	2730
2021 Q1	$258K	Buy	29,261 +700	+2%	+$7.68K	﹤0.01%	2728
2020 Q4	$292K	Hold	28,561	–	–	﹤0.01%	2481
2020 Q3	$258K	Hold	28,561	–	–	﹤0.01%	2373
2020 Q2	$204K	Buy	+28,561	New	+$303K	﹤0.01%	2487

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Raymond James Financial Services Advisors's GRTX Position: Q2 2023 in Review

Raymond James Financial Services Advisors sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2023, closing a stake of 23,475 shares — an estimated $60.1K sold.

Raymond James Financial Services Advisors first reported a position in GRTX in Q2 2020 and held it in 11 quarters. The position peaked at $297K in Q2 2021. 55 funds tracked by Wall St. Rank hold GRTX as of Q2 2023.

Raymond James Financial Services Advisors reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Raymond James Financial Services Advisors sold 23,475 Galera Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $60.1K.
Raymond James Financial Services Advisors first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
Raymond James Financial Services Advisors's Galera Therapeutics, Inc. Common Stock position peaked at $297K in Q2 2021.
55 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2023, filed 25 Jul 2023.